Success Connection
Webcast Presentations and Training
http://www.MyEConference.org
** Note: All webcast times are listed in Pacific Time Zone. **
Featured Webcasts for February 24 - March 1:
Health & Freedom
Dave and Deanna Waters are Diamond Directors, members of the Million Dollar Club and members of the 10-member Independent Distributors Council for North America. In 2006, they were awarded the Dr. Wentz Vision Award, which is presented to an outstanding Associate who endeavors to improve the health of everyone they meet and reduce the mental and physical suffering of all people. Dave was a national television Director/Producer for the Canadian Broadcasting Corporation for his career, and very involved in the music industry in Winnipeg. Deanna enjoyed a varied career in management, the latest two endeavors as Executive Director of Take Pride Winnipeg, an environmental organization, and Director of Communications and Marketing for Winnipeg Economic Development Corporation.
Monday, February 25 (6:00 - 7:00 pm) *
Health & Freedom Room
Health & Freedom
When they were introduced to USANA, Ruby Directors Jim & Dian Fawver were hopeful but skeptical. After 30 years in executive management with IBM, they didn't see how something could be so good. But they also didn't want to "slave away" at a job for the rest of their lives either. That skepticism turned into excitement as they realized how much fun they could have while improving their health, meeting new and wonderful people, and making an income commensurate or better than their prior careers. They are passionate about wanting others to achieve their joy.
Tuesday, February 26 (6:00 - 7:00 pm) *
Health & Freedom Room
Training
Gold Director, Annette Walbon, is passionate about training. She has created a team with a focus on retention, which has solidified her success in USANA. She is excited to help you train your new Associates about the basics of USANA. In this training, Annette covers your Partners and Resources, the Definition of a USANA Business, and Successful Foundations, Your Beliefs and the "Entrepreneurial Mindset."
Monday, February 25 (6:00 - 7:00 pm) *
Education & Training Room
Weekly Events in the Health & Freedom Room:
Every Tuesday at 6pm- H/F Presentation, Rotating Speakers
Weekly Events in the Training Room:
Every Monday at 6pm- Getting Started Training with Annette Walbon
Weekly Health & Freedom Presentations in Other Languages:
1st Wednesday of each month - Mandarin Chinese
3rd Friday of each month - Cantonese
Weekly Webcasts in the Special Events Room:
Click here for the complete calendar of events
Showing posts with label Alternative Healthcare Professional. Show all posts
Showing posts with label Alternative Healthcare Professional. Show all posts
Friday, February 22, 2008
Tuesday, February 5, 2008
THIS IS WHY ITS USANA FOR ME-- JUST THIS REASON
SAN JUAN, Puerto Rico – The first warning sign came when a sharp-eyed worker sorting pills noticed that the odd blue flecks dotting the finished drug capsules matched the paint on the factory doors.
After the flecks were spotted again on the capsules, a blood-pressure medication called Diltiazem, the plant began placing covers over drugs in carts in its manufacturing areas.
But the factory owner, Canadian drug maker Biovail Corp., never tried to find out whether past shipments of the drug were contaminated – or prevent future contamination, according to U.S. regulators.
Thirteen of the 20 best-selling drugs in the United States come from plants on this island. But an investigation by The Associated Press has found dozens of examples over four years of lapses in quality control in the Puerto Rican pharmaceutical industry, which churns out $35 billion of drugs each year, most of it for sale as part of the $300 billion market in the U.S.
An AP review of 100 pages of Food and Drug Administration reports shows even modern drug plants here under the watch of U.S. regulators have failed to keep laboratories sterile and have exported tainted pills.
“People would be shocked to find this whole variety of contamination,” said Dr. Sidney Wolfe of the Washington watchdog group Public Citizen. “The common denominator of all these is there's really poor quality control.”
FDA officials say the problems in Puerto Rico are proportionate with the large number of pharmaceutical plants here and generally no worse than those on the U.S. mainland.
Consumer advocates say they demonstrate the regulatory agency does not sufficiently monitor the industry across Puerto Rico and in the mainland.
The FDA issued a warning letter to Wyeth in May 2006, after consumers reported finding machinery pins inside bottles of Effexor, a leading depression treatment, and the heartburn drug Protonix. The letter expressed concern that the plant was not “able to detect that the affected equipment was missing some of its parts.” The Madison, N.J.-based company faulted mistakes by workers who packaged the drugs.
In another case cited in a June 2006 FDA inspection report, a plant owned by Teva Pharmaceutical Industries exported drugs – including the diabetes treatment Metformin – even though they were known to contain small amounts of metal particles. The company had also received at least six consumer complaints of dark residue inside bottles or foreign material embedded in tablets, according to the report.
Teva's quality-control unit said the presence of some metallic material was to be expected because the manufacturing equipment is made of metal, according to the report.
Teva recalled 21 different drugs as a result of the inspection, according to FDA officials, and the Israeli drugmaker announced two months later it was closing the plant, citing a restructuring.
Denise Bradley, a Teva spokeswoman, insisted the medicine from the now-closed plant was safe and effective despite the contamination.
The reports obtained by AP were produced by FDA inspections from 2003 to 2007 of 13 pharmaceutical plants – roughly half the total in this U.S. territory, a Caribbean island with one of the world's highest concentrations of drug makers.
Several are closing or downsizing as the expense of updating decades-old plants to meet regulations adds to struggles with rising energy costs and tightening tax breaks.
The FDA often hesitates to crack down at the first sign of problems because manufacturers can chalk them up to isolated mishaps, said John Scharmann, a former FDA administrator for the Denver district now associated with a watchdog group.
That appeared to be the case at the Biovail-owned factory in the San Juan suburb of Carolina where the sharp-eyed worker noticed the foreign specks of blue.
“Incident was considered an isolated event ... even when the employee reported having observed the same particles before,” the report said.
David Elder, director of enforcement in FDA's regulatory affairs office, said pharmaceutical companies generally fix problems on their own and issue recalls if necessary once notified.
“They're making products that save or support lives, so it's not in their interest to make products that are unsafe or ineffective,” he said. “I think they're good corporate citizens by and large and want to do right by their patients.”
Four of the plants described in the reports closed or announced plans to do so after the discovery of significant quality-control problems, but none of them cited the discoveries as a reason for closing.
One of those four, GlaxoSmithKline PLC, produced tablets of the popular antidepressant Paxil CR that split apart, potentially causing patients to take incorrect dosages.
When the company would not recall all the affected pills, U.S. marshals raided the plant in March 2005 in the largest drug seizure in FDA history and also collected tablets of the diabetes treatment Avandamet after some were found not to have accurate doses of the active ingredient.
Some plants in Puerto Rico are three decades old, built when the territory's pharmaceutical industry took off thanks to tax incentives aimed at developing more high-tech manufacturing.
The industry here has faded somewhat. Companies have shed more than 3,000 jobs in the last 18 months and closed several plants for a variety of reasons, including the loss of federal tax breaks and cost-cutting.
Still, this island turns out some top-selling drugs on the U.S. market, including cholesterol drugs Lipitor and Zocor, the blood-thinner Plavix, anemia drugs Aranesp and Epogen and the antidepressant Zoloft.
The FDA's San Juan office has 22 inspectors who devote about a quarter of their time to pharmaceutical plants. They typically visit the factories once every two years, more often if there are consumer complaints or the company has repeated infractions.
Factories confronted with violations often make extensive changes. The Biovail plant invested $5 million in equipment upgrades and addressed problems including errant metal particles from cleaning spatulas. A follow-up FDA inspection found no problems, said Gilbert Godin, executive vice president of the Ontario-based company.
Scharmann, a consulting editor for the watchdog publication Dickinson's FDA Review, said the FDA is concerned by anything that affects drug quality but considers the likelihood that the companies may file legal challenges to enforcement actions.
“There's a fairly broad latitude that is allowed,” Scharmann said.
Elder contends inspections are rigorous.
“The folks doing this work aren't just regulators. That's our job, but we're also consumers of these products,” he said. “It's personal to us to make sure these products are in compliance.”
Keywords:
AHA Scientific Statements, Alice Clegg, Alternative Medicine, antioxidants, body building, Business Opportunity, Calcium, California, Cancer, cardiovascular, diseases, cooking, diets, fitness, food, health, health and freedom, Jason Kilgore, Kilgore and USANA, Kilgore Defense Institute, Kilgore MMA, Martial Arts, men’s health, Mexico USANA, Minerals, mydreams.usana.com, nutrition, Healthy Brain, Cardiorespiratory fitness, nutritional, Recipes, Safety, Sierra Foothills Karate, nutrition, advice, sports, Sports Health, Sports Nutrition, Acupressure, Stress Management, USANA, Usana and Alice Clegg, Usana and Jason Kilgore, Usana and Sierra Foothills Karate, USANA HEALTH SCIENCES, USANA HEALTH SCIENCES DISTRIBUTOR, Traditional Chinese medicine, massage, herbs, botany, marine biology, aquaculture, sea, ocean, Utah, vitamins, wellness, Wellness Misphitz, women, fitness, womens health, Tim Sales, Naturopathic Medicine, integritas group, STI, Health and Freedom, Oriental Medicine, Acupuncture, DAOM, OMD, Metabolic Syndrome, Skin conditions, Journal of Family Practice, Complementary & Alternative Medicine, homeopathic remedies, B vitamins -- folic acid and B12, Alternative Healthcare Professional, Mind Body Health, Cherimoya, Massage Programs, Body Therapy Programs, Asian Holistic Health & massage, Chinese and other Asian systems of medicine, Tui Na Certificate, Tui Na Hand Techniques, CPR/First Aid, Asian Body Therapy, safeliving@usana.com, Mexico USANA, Ocean Conservancy
After the flecks were spotted again on the capsules, a blood-pressure medication called Diltiazem, the plant began placing covers over drugs in carts in its manufacturing areas.
But the factory owner, Canadian drug maker Biovail Corp., never tried to find out whether past shipments of the drug were contaminated – or prevent future contamination, according to U.S. regulators.
Thirteen of the 20 best-selling drugs in the United States come from plants on this island. But an investigation by The Associated Press has found dozens of examples over four years of lapses in quality control in the Puerto Rican pharmaceutical industry, which churns out $35 billion of drugs each year, most of it for sale as part of the $300 billion market in the U.S.
An AP review of 100 pages of Food and Drug Administration reports shows even modern drug plants here under the watch of U.S. regulators have failed to keep laboratories sterile and have exported tainted pills.
“People would be shocked to find this whole variety of contamination,” said Dr. Sidney Wolfe of the Washington watchdog group Public Citizen. “The common denominator of all these is there's really poor quality control.”
FDA officials say the problems in Puerto Rico are proportionate with the large number of pharmaceutical plants here and generally no worse than those on the U.S. mainland.
Consumer advocates say they demonstrate the regulatory agency does not sufficiently monitor the industry across Puerto Rico and in the mainland.
The FDA issued a warning letter to Wyeth in May 2006, after consumers reported finding machinery pins inside bottles of Effexor, a leading depression treatment, and the heartburn drug Protonix. The letter expressed concern that the plant was not “able to detect that the affected equipment was missing some of its parts.” The Madison, N.J.-based company faulted mistakes by workers who packaged the drugs.
In another case cited in a June 2006 FDA inspection report, a plant owned by Teva Pharmaceutical Industries exported drugs – including the diabetes treatment Metformin – even though they were known to contain small amounts of metal particles. The company had also received at least six consumer complaints of dark residue inside bottles or foreign material embedded in tablets, according to the report.
Teva's quality-control unit said the presence of some metallic material was to be expected because the manufacturing equipment is made of metal, according to the report.
Teva recalled 21 different drugs as a result of the inspection, according to FDA officials, and the Israeli drugmaker announced two months later it was closing the plant, citing a restructuring.
Denise Bradley, a Teva spokeswoman, insisted the medicine from the now-closed plant was safe and effective despite the contamination.
The reports obtained by AP were produced by FDA inspections from 2003 to 2007 of 13 pharmaceutical plants – roughly half the total in this U.S. territory, a Caribbean island with one of the world's highest concentrations of drug makers.
Several are closing or downsizing as the expense of updating decades-old plants to meet regulations adds to struggles with rising energy costs and tightening tax breaks.
The FDA often hesitates to crack down at the first sign of problems because manufacturers can chalk them up to isolated mishaps, said John Scharmann, a former FDA administrator for the Denver district now associated with a watchdog group.
That appeared to be the case at the Biovail-owned factory in the San Juan suburb of Carolina where the sharp-eyed worker noticed the foreign specks of blue.
“Incident was considered an isolated event ... even when the employee reported having observed the same particles before,” the report said.
David Elder, director of enforcement in FDA's regulatory affairs office, said pharmaceutical companies generally fix problems on their own and issue recalls if necessary once notified.
“They're making products that save or support lives, so it's not in their interest to make products that are unsafe or ineffective,” he said. “I think they're good corporate citizens by and large and want to do right by their patients.”
Four of the plants described in the reports closed or announced plans to do so after the discovery of significant quality-control problems, but none of them cited the discoveries as a reason for closing.
One of those four, GlaxoSmithKline PLC, produced tablets of the popular antidepressant Paxil CR that split apart, potentially causing patients to take incorrect dosages.
When the company would not recall all the affected pills, U.S. marshals raided the plant in March 2005 in the largest drug seizure in FDA history and also collected tablets of the diabetes treatment Avandamet after some were found not to have accurate doses of the active ingredient.
Some plants in Puerto Rico are three decades old, built when the territory's pharmaceutical industry took off thanks to tax incentives aimed at developing more high-tech manufacturing.
The industry here has faded somewhat. Companies have shed more than 3,000 jobs in the last 18 months and closed several plants for a variety of reasons, including the loss of federal tax breaks and cost-cutting.
Still, this island turns out some top-selling drugs on the U.S. market, including cholesterol drugs Lipitor and Zocor, the blood-thinner Plavix, anemia drugs Aranesp and Epogen and the antidepressant Zoloft.
The FDA's San Juan office has 22 inspectors who devote about a quarter of their time to pharmaceutical plants. They typically visit the factories once every two years, more often if there are consumer complaints or the company has repeated infractions.
Factories confronted with violations often make extensive changes. The Biovail plant invested $5 million in equipment upgrades and addressed problems including errant metal particles from cleaning spatulas. A follow-up FDA inspection found no problems, said Gilbert Godin, executive vice president of the Ontario-based company.
Scharmann, a consulting editor for the watchdog publication Dickinson's FDA Review, said the FDA is concerned by anything that affects drug quality but considers the likelihood that the companies may file legal challenges to enforcement actions.
“There's a fairly broad latitude that is allowed,” Scharmann said.
Elder contends inspections are rigorous.
“The folks doing this work aren't just regulators. That's our job, but we're also consumers of these products,” he said. “It's personal to us to make sure these products are in compliance.”
Keywords:
AHA Scientific Statements, Alice Clegg, Alternative Medicine, antioxidants, body building, Business Opportunity, Calcium, California, Cancer, cardiovascular, diseases, cooking, diets, fitness, food, health, health and freedom, Jason Kilgore, Kilgore and USANA, Kilgore Defense Institute, Kilgore MMA, Martial Arts, men’s health, Mexico USANA, Minerals, mydreams.usana.com, nutrition, Healthy Brain, Cardiorespiratory fitness, nutritional, Recipes, Safety, Sierra Foothills Karate, nutrition, advice, sports, Sports Health, Sports Nutrition, Acupressure, Stress Management, USANA, Usana and Alice Clegg, Usana and Jason Kilgore, Usana and Sierra Foothills Karate, USANA HEALTH SCIENCES, USANA HEALTH SCIENCES DISTRIBUTOR, Traditional Chinese medicine, massage, herbs, botany, marine biology, aquaculture, sea, ocean, Utah, vitamins, wellness, Wellness Misphitz, women, fitness, womens health, Tim Sales, Naturopathic Medicine, integritas group, STI, Health and Freedom, Oriental Medicine, Acupuncture, DAOM, OMD, Metabolic Syndrome, Skin conditions, Journal of Family Practice, Complementary & Alternative Medicine, homeopathic remedies, B vitamins -- folic acid and B12, Alternative Healthcare Professional, Mind Body Health, Cherimoya, Massage Programs, Body Therapy Programs, Asian Holistic Health & massage, Chinese and other Asian systems of medicine, Tui Na Certificate, Tui Na Hand Techniques, CPR/First Aid, Asian Body Therapy, safeliving@usana.com, Mexico USANA, Ocean Conservancy
Raw Food Materia Medica - Cherimoya
Raw Food Materia Medica - Cherimoya
Cherimoya, also known as "Custard apple" is native to the tropics of South America. Its genus name is from an ancient Incan word, annona and means "year's harvest." It is a member of the Anonaceae (Custard Apple) Family and relative of Soursop. Inside the spiky yellow green skin is a lush white flesh with a delicious flavor, similar to a combination of banana, blueberry and pineapple. Cherimoyas are cooling. They have been used to remedy acidosis, bad breath, constipation, kidney and bladder inflammation. Cherimoyas are high in vitamin C, calcium, and iron. View More
Keywords:
Traditional Chinese medicine, massage, herbs, botany, marine biology, aquaculture, sea, ocean, Utah, vitamins, wellness, Wellness Misphitz, women, fitness, womens health, Tim Sales, Naturopathic Medicine, integritas group, STI, Health and Freedom, Oriental Medicine, Acupuncture, DAOM, OMD, Metabolic Syndrome, Skin conditions, Journal of Family Practice, Complementary & Alternative Medicine, homeopathic remedies, B vitamins -- folic acid and B12, Alternative Healthcare Professional, Mind Body Health, Cherimoya, Massage Programs, Body Therapy Programs, Asian Holistic Health & massage, Chinese and other Asian systems of medicine, Tui Na Certificate, Tui Na Hand Techniques, CPR/First Aid, Asian Body Therapy, safeliving@usana.com, Mexico USANA, Ocean Conservancy
Cherimoya, also known as "Custard apple" is native to the tropics of South America. Its genus name is from an ancient Incan word, annona and means "year's harvest." It is a member of the Anonaceae (Custard Apple) Family and relative of Soursop. Inside the spiky yellow green skin is a lush white flesh with a delicious flavor, similar to a combination of banana, blueberry and pineapple. Cherimoyas are cooling. They have been used to remedy acidosis, bad breath, constipation, kidney and bladder inflammation. Cherimoyas are high in vitamin C, calcium, and iron. View More
Keywords:
Traditional Chinese medicine, massage, herbs, botany, marine biology, aquaculture, sea, ocean, Utah, vitamins, wellness, Wellness Misphitz, women, fitness, womens health, Tim Sales, Naturopathic Medicine, integritas group, STI, Health and Freedom, Oriental Medicine, Acupuncture, DAOM, OMD, Metabolic Syndrome, Skin conditions, Journal of Family Practice, Complementary & Alternative Medicine, homeopathic remedies, B vitamins -- folic acid and B12, Alternative Healthcare Professional, Mind Body Health, Cherimoya, Massage Programs, Body Therapy Programs, Asian Holistic Health & massage, Chinese and other Asian systems of medicine, Tui Na Certificate, Tui Na Hand Techniques, CPR/First Aid, Asian Body Therapy, safeliving@usana.com, Mexico USANA, Ocean Conservancy
Subscribe to:
Posts (Atom)
